Calypso, Varian combine cancer tech:
This article was originally published in Clinica
Executive Summary
Tumour detection specialist Calypso Medical has announced plans to combine its Calypso 4D Localization System with Varian Medical Systems' treatment planning system and linear accelerators to enhance radiotherapy treatment. The 4D system, which Calypso (Seattle, Washington) claims is the first device to use a non-ionizing approach for target localisation in treatment setup and monitoring during radiation therapy delivery, aims to give clinicians improved patient positioning, motion management and tumour targeting when integrated with Varian's Eclipse and On Board Imager technologies. Integration of the 4D system and Eclipse is expected to begin after the 4D's launch - it received FDA 510(k) clearance for use in prostate therapy only in July 2006.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.